RESTYLANE®, the Original Stabilized Hyaluronic Acid Filler, Celebrates 25 Years of Unmatched Achievement
Retrieved on:
Thursday, September 30, 2021
Other Consumer, Biotechnology, Other Health, Health, Cosmetics, Consumer, Retail, Other Science, Science, LYFT, Food, Partnership, Poster, CFDA, Achievement, Regulation of tobacco by the U.S. Food and Drug Administration, Hyaluronic acid, FDA, Patient, NMPA, Facial expression, Talarico, Bajaj Consumer Care, GAIN, Scottish Fold, MPH, National Medical Products Administration, Dermatology, Safety, Skin, Pharmaceutical industry, Cosmetics, Paint, Galderma, Galderma’s RESTYLANE portfolio, GALDERMA, GALDERMA’S RESTYLANE PORTFOLIO
The original non-animal stabilized hyaluronic acid filler restores, enhances and refreshes the youthful-looking appearance of the skin.
Key Points:
- The original non-animal stabilized hyaluronic acid filler restores, enhances and refreshes the youthful-looking appearance of the skin.
- RESTYLANE is the original non-animal stabilized hyaluronic acid filler with over 25 years of achievement and over 50 million treatments worldwide.
- High Patient Satisfaction of a Hyaluronic Acid FillerProducing Enduring Full-Facial Volume Restoration: An18-Month Open Multicenter Study.
- Perioral rejuvenation with a range of customized hyaluronic acid fillers: efficacy and safety over six months with a specific focus on the lips.